355 related articles for article (PubMed ID: 31034957)
41. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis.
Wu XN; Yang ZH; Wang XK; Zhang Y; Wan H; Song Y; Chen X; Shao J; Han J
Cell Death Differ; 2014 Nov; 21(11):1709-20. PubMed ID: 24902902
[TBL] [Abstract][Full Text] [Related]
42. Necroptosis in cancer: An angel or a demon?
Wang T; Jin Y; Yang W; Zhang L; Jin X; Liu X; He Y; Li X
Tumour Biol; 2017 Jun; 39(6):1010428317711539. PubMed ID: 28651499
[TBL] [Abstract][Full Text] [Related]
43. Connections between various trigger factors and the RIP1/ RIP3 signaling pathway involved in necroptosis.
Zhang YY; Liu H
Asian Pac J Cancer Prev; 2013; 14(12):7069-74. PubMed ID: 24460252
[TBL] [Abstract][Full Text] [Related]
44. Assays for necroptosis and activity of RIP kinases.
Degterev A; Zhou W; Maki JL; Yuan J
Methods Enzymol; 2014; 545():1-33. PubMed ID: 25065884
[TBL] [Abstract][Full Text] [Related]
45. Necroptosis: an emerging form of programmed cell death.
Wu W; Liu P; Li J
Crit Rev Oncol Hematol; 2012 Jun; 82(3):249-58. PubMed ID: 21962882
[TBL] [Abstract][Full Text] [Related]
46. The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells.
Zhang M; Harashima N; Moritani T; Huang W; Harada M
PLoS One; 2015; 10(5):e0127386. PubMed ID: 26000607
[TBL] [Abstract][Full Text] [Related]
47. Hyperglycemic Conditions Prime Cells for RIP1-dependent Necroptosis.
LaRocca TJ; Sosunov SA; Shakerley NL; Ten VS; Ratner AJ
J Biol Chem; 2016 Jun; 291(26):13753-61. PubMed ID: 27129772
[TBL] [Abstract][Full Text] [Related]
48. Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway.
Xin J; You D; Breslin P; Li J; Zhang J; Wei W; Cannova J; Volk A; Gutierrez R; Xiao Y; Ni A; Ng G; Schmidt R; Xia Z; Pan J; Chen H; Patel MM; Kuo PC; Nand S; Kini AR; Zhang J; Chen J; Zhu J; Zhang J
Leukemia; 2017 May; 31(5):1154-1165. PubMed ID: 27748372
[TBL] [Abstract][Full Text] [Related]
49. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.
Vandenabeele P; Declercq W; Van Herreweghe F; Vanden Berghe T
Sci Signal; 2010 Mar; 3(115):re4. PubMed ID: 20354226
[TBL] [Abstract][Full Text] [Related]
50. Rucaparip (Rubraca
Wang Y; Zheng Y; Hao Y
Pharmazie; 2020 Jun; 75(6):242-245. PubMed ID: 32539918
[TBL] [Abstract][Full Text] [Related]
51. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S
Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688
[TBL] [Abstract][Full Text] [Related]
52. RIP1 is a central signaling protein in regulation of TNF-α/TRAIL mediated apoptosis and necroptosis during Newcastle disease virus infection.
Liao Y; Wang HX; Mao X; Fang H; Wang H; Li Y; Sun Y; Meng C; Tan L; Song C; Qiu X; Ding C
Oncotarget; 2017 Jun; 8(26):43201-43217. PubMed ID: 28591723
[TBL] [Abstract][Full Text] [Related]
53. Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway.
Schock SN; Chandra NV; Sun Y; Irie T; Kitagawa Y; Gotoh B; Coscoy L; Winoto A
Cell Death Differ; 2017 Apr; 24(4):615-625. PubMed ID: 28060376
[TBL] [Abstract][Full Text] [Related]
54. RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease.
Lin QS; Chen P; Wang WX; Lin CC; Zhou Y; Yu LH; Lin YX; Xu YF; Kang DZ
Lab Invest; 2020 Mar; 100(3):503-511. PubMed ID: 31506635
[TBL] [Abstract][Full Text] [Related]
55. Coeloglossum viride var. bracteatum extract attenuates Aβ-induced toxicity by inhibiting RIP1-driven inflammation and necroptosis.
Li XX; Lang XY; Ren TT; Wang J; Lan R; Qin XY
J Ethnopharmacol; 2022 Jan; 282():114606. PubMed ID: 34506939
[TBL] [Abstract][Full Text] [Related]
56. Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways.
Li Y; Tian X; Liu X; Gong P
Carcinogenesis; 2018 May; 39(5):700-707. PubMed ID: 29546393
[TBL] [Abstract][Full Text] [Related]
57. Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
Cougnoux A; Cluzeau C; Mitra S; Li R; Williams I; Burkert K; Xu X; Wassif CA; Zheng W; Porter FD
Cell Death Dis; 2016 Mar; 7(3):e2147. PubMed ID: 26986514
[TBL] [Abstract][Full Text] [Related]
58. Nuclear translocation of MLKL enhances necroptosis by a RIP1/RIP3-independent mechanism in H9c2 cardiomyoblasts.
Ino S; Yano T; Kuno A; Tanno M; Kouzu H; Sato T; Yamashita T; Ohwada W; Osanami A; Ogawa T; Toda Y; Shimizu M; Miura T
J Pharmacol Sci; 2023 Feb; 151(2):134-143. PubMed ID: 36707179
[TBL] [Abstract][Full Text] [Related]
59. RIP1 promotes proliferation through G2/M checkpoint progression and mediates cisplatin-induced apoptosis and necroptosis in human ovarian cancer cells.
Zheng XL; Yang JJ; Wang YY; Li Q; Song YP; Su M; Li JK; Zhang L; Li ZP; Zhou B; Lin Y
Acta Pharmacol Sin; 2020 Sep; 41(9):1223-1233. PubMed ID: 32242118
[TBL] [Abstract][Full Text] [Related]
60. Necroptosis mediated by receptor interaction protein kinase 1 and 3 aggravates chronic kidney injury of subtotal nephrectomised rats.
Zhu Y; Cui H; Gan H; Xia Y; Wang L; Wang Y; Sun Y
Biochem Biophys Res Commun; 2015 Jun; 461(4):575-81. PubMed ID: 25907058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
